A telemetry-instrumentation system for monitoring multiple subcutaneously implanted glucose sensors.
IEEE Trans Biomed Eng
; 41(10): 937-42, 1994 Oct.
Article
in En
| MEDLINE
| ID: mdl-7959800
An implantable potentiostat-radiotelemetry system for in vivo sensing of glucose is described. An enzyme electrode sensor measures the oxidation current of hydrogen peroxide formed by the stoichiometric conversion of glucose substrate and oxygen cofactor in an immobilized glucose oxidase layer. The sensor current is converted to a frequency and transmitted at programmable intervals (4, 32, 256 s) to a remote receiver. Low power CMOS circuitry is employed and device operation for up to 1.5 years is predicted using two series connected 250 mAh lithium cells. Crystal controlled RF frequencies uniquely identify each sensor allowing over 10 sensors within the same 10 m radius. A custom interface card allows a PC to program the receiver and handle the transmitted sensor data using software written in Microsoft C and QuickBasic. Software control allows on-the-fly sensor addition or subtraction to the sensor group being monitored. Over 10 sensors can be tracked long-term using the longest transmit interval, or four sensors can be tracked during short-term infusion studies when the transmit interval is reduced to 4 s. The design, construction, operation, and performance of the system hardware and software are described and evaluated.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostheses and Implants
/
Telemetry
/
Blood Glucose
Limits:
Animals
Language:
En
Journal:
IEEE Trans Biomed Eng
Year:
1994
Document type:
Article
Country of publication:
United States